A detailed history of Marshall Wace, LLP transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 813,594 shares of TNDM stock, worth $25.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
813,594
Previous 524,393 55.15%
Holding current value
$25.1 Million
Previous $21.1 Million 63.28%
% of portfolio
0.04%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$35.21 - $47.3 $10.2 Million - $13.7 Million
289,201 Added 55.15%
813,594 $34.5 Million
Q2 2024

Aug 14, 2024

SELL
$30.43 - $53.43 $79 Million - $139 Million
-2,595,981 Reduced 83.19%
524,393 $21.1 Million
Q1 2024

May 15, 2024

BUY
$22.09 - $35.41 $61.2 Million - $98 Million
2,768,459 Added 786.68%
3,120,374 $110 Million
Q4 2023

Feb 14, 2024

BUY
$14.28 - $31.03 $2.47 Million - $5.36 Million
172,875 Added 96.56%
351,915 $10.4 Million
Q3 2023

Nov 14, 2023

SELL
$19.33 - $36.22 $9.24 Million - $17.3 Million
-478,121 Reduced 72.76%
179,040 $3.72 Million
Q2 2023

Aug 14, 2023

BUY
$24.18 - $42.46 $15.9 Million - $27.9 Million
657,161 New
657,161 $16.1 Million
Q4 2022

Feb 14, 2023

BUY
$35.49 - $56.15 $31.3 Million - $49.5 Million
881,307 New
881,307 $39.6 Million
Q2 2022

Aug 15, 2022

SELL
$53.22 - $123.09 $1.31 Million - $3.04 Million
-24,703 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$101.89 - $150.09 $5.67 Million - $8.36 Million
-55,673 Reduced 69.27%
24,703 $2.87 Million
Q4 2021

Feb 14, 2022

BUY
$118.18 - $153.21 $7.63 Million - $9.89 Million
64,572 Added 408.58%
80,376 $12.1 Million
Q3 2021

Nov 15, 2021

BUY
$93.51 - $129.4 $1.48 Million - $2.05 Million
15,804 New
15,804 $1.89 Million
Q2 2021

Aug 13, 2021

SELL
$77.0 - $100.19 $369,215 - $480,411
-4,795 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$81.28 - $104.34 $52,506 - $67,403
646 Added 15.57%
4,795 $424,000
Q4 2020

Feb 16, 2021

SELL
$86.4 - $121.75 $793,497 - $1.12 Million
-9,184 Reduced 68.88%
4,149 $397,000
Q3 2020

Nov 16, 2020

BUY
$95.43 - $116.09 $328,565 - $399,697
3,443 Added 34.81%
13,333 $1.51 Million
Q2 2020

Aug 13, 2020

BUY
$60.05 - $98.92 $593,894 - $978,318
9,890 New
9,890 $978,000
Q1 2020

May 15, 2020

SELL
$47.37 - $90.04 $243,481 - $462,805
-5,140 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$53.13 - $71.19 $182,395 - $244,395
-3,433 Reduced 40.04%
5,140 $306,000
Q3 2019

Nov 14, 2019

BUY
$57.11 - $73.3 $162,135 - $208,098
2,839 Added 49.51%
8,573 $506,000
Q2 2019

Aug 14, 2019

BUY
$54.41 - $71.7 $311,986 - $411,127
5,734 New
5,734 $370,000
Q1 2019

May 14, 2019

SELL
$32.25 - $73.56 $474,042 - $1.08 Million
-14,699 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $418,186 - $597,514
14,699 New
14,699 $558,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.98B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.